Acasă » Academic Repository » Domain » Applied sciences » Medicine and health » INSULIN RESISTANCE – A CONSEQUENCE IN PATIENTS TREATED WITH STEROID ANTI-INFLAMMATORY DRUGS FOR COVID 19

INSULIN RESISTANCE – A CONSEQUENCE IN PATIENTS TREATED WITH STEROID ANTI-INFLAMMATORY DRUGS FOR COVID 19

0,00 lei

somdn_product_page

(Downloads - 0)

Description

Delia LESPEZEANU, Dan Florin UNGUREANU

Antimicrobial resistance, has become a pulmonary problem of acute exacerbation, but treated with antibiotics, norfloxacin 400 mg 1, with a prophylactic benefits, of long term, with spontaneous absortion, combined with molnupiravir, in COVID-19, in people over 65 years, by using biological laboratory, as procalcitonin, PCR, D-Dimer, LDH (lactate dehydrogenase) and fibrinogen with cytokine levels IL-1, IL-6, with typical symptoms for the first 7-10 days.

https://doi.org/10.58679/UTM82089

Reviews

There are no reviews yet.

Be the first to review “INSULIN RESISTANCE – A CONSEQUENCE IN PATIENTS TREATED WITH STEROID ANTI-INFLAMMATORY DRUGS FOR COVID 19”

Your email address will not be published. Required fields are marked *